Preemptive treatment of early donor‐specific antibodies with IgA‐ and IgM‐enriched intravenous human immunoglobulins in lung transplantation

This retrospective study presents our 4‐year experience of preemptive treatment of early anti‐HLA donor specific antibodies with IgA‐ and IgM‐enriched immunoglobulins. We compared outcomes between patients with antibodies and treatment (case patients) and patients without antibodies (control patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Ius, Fabio, Verboom, Murielle, Sommer, Wiebke, Poyanmehr, Reza, Knoefel, Ann‐Kathrin, Salman, Jawad, Kuehn, Christian, Avsar, Murat, Siemeni, Thierry, Erdfelder, Caroline, Hallensleben, Michael, Boethig, Dietmar, Schwerk, Nicolaus, Mueller, Carsten, Welte, Tobias, Falk, Christine, Haverich, Axel, Tudorache, Igor, Warnecke, Gregor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585979/
https://www.ncbi.nlm.nih.gov/pubmed/29719115
http://dx.doi.org/10.1111/ajt.14912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585979/
https://www.ncbi.nlm.nih.gov/pubmed/29719115
http://dx.doi.org/10.1111/ajt.14912

Ejemplares similares